Tissue Allografts and Health Risks
Overview
Authors
Affiliations
Like vascularized transplants, tissue allografts are able to transmit viral and bacterial diseases. Transmission of HIV (Human Immunodeficiency Virus) and HCV (Hepatitis C virus) has been proved for sterilized, unprocessed and deep-frozen allografts. It is the prime responsibility of the tissue bank to select the donor correctly and to perform careful biological screening. However, standard screening is not enough to detect a seronegative but contaminated donor. It is necessary to quarantine the tissues until complementary screening confirms the absence of viral disease. If secondary screening is not possible, the tissues should be discarded or should be processed. If donor selection, relevant and appropriate screening tests and adequate procurement of tissues are carefully made, then the risk of disease transmission from tissue allografts will remain remote.
FDA-approved bone grafts and bone graft substitute devices in bone regeneration.
Gillman C, Jayasuriya A Mater Sci Eng C Mater Biol Appl. 2021; 130:112466.
PMID: 34702541 PMC: 8555702. DOI: 10.1016/j.msec.2021.112466.
Grassi F, Grassi R, Vivarelli L, Dallari D, Govoni M, Nardi G Materials (Basel). 2020; 13(6).
PMID: 32204393 PMC: 7142634. DOI: 10.3390/ma13061393.
Risk of virus transmission through femoral head allografts: A Belgian appraisal.
Traore A, Yombi J, Tribak K, Cornu O J Clin Orthop Trauma. 2015; 4(3):119-22.
PMID: 26403550 PMC: 3880425. DOI: 10.1016/j.jcot.2013.07.001.
Human tissue allograft processing: impact on in vitro and in vivo biocompatibility.
Fawzi-Grancher S, Goebbels R, Bigare E, Cornu O, Gianello P, Delloye C J Mater Sci Mater Med. 2009; 20(8):1709-20.
PMID: 19301101 DOI: 10.1007/s10856-009-3726-0.